Alzheimer's and Parkinson's Diseases
Alzheimer’s and Parkinson’s diseases are two of the most prevalent neurodegenerative disorders that primarily affect older populations. Alzheimer’s disease is characterized by progressive memory loss, confusion, and behavioral changes, largely due to the accumulation of amyloid plaques and tau tangles in the brain, leading to neuron death. Parkinson’s disease, on the other hand, primarily affects movement, causing tremors, rigidity, bradykinesia (slowness of movement), and postural instability due to the loss of dopamine-producing neurons in the substantia nigra. Both diseases have a significant impact on the quality of life, and while there are treatments aimed at alleviating symptoms (e.g., dopamine replacement for Parkinson's), no cure currently exists. Research is focusing on early detection, neuroprotective therapies, and understanding the genetic and environmental factors contributing to these diseases. Advanced neuroimaging, biomarker discovery, and clinical trials hold promise for improving outcomes and eventually finding more effective treatments.